Results 161 to 170 of about 10,614 (201)

Comparative risk of systemic autoimmune diseases in juvenile idiopathic arthritis treated with TNF-α or IL-6 inhibitors: a real-world cohort study. [PDF]

Front Immunol
Tsai JJ, Liu LT, Lin PC, Wang YH, Lee YH, Wei JC.   +5 more
europepmc   +1 more source

Systemic Lupus Erythematosus-Associated Thrombotic Thrombocytopenic Purpura: A Case Report. [PDF]

Cureus
Es-Saad O, Zyani A, Bouchlaghem A, Alkouh R, Labib S.   +4 more
europepmc   +1 more source

A Case of Acute Kidney Injury During Eltrombopag Use Successfully Treated With Plasma Exchange in Addition to Antithrombotic Therapy. [PDF]

Kidney Med
Ueno N, Kusunoki Y, Kida T, Oda S, Yamano A, Nakayama F, Fukuda S, Ikeda N, Namba-Hamano T, Homma M, Takeji M.   +10 more
europepmc   +1 more source

Case report: Successful therapy with recombinant human vascular endostatin in an elderly man with colon telangiectasia and idiopathic thrombocytopenic purpura. [PDF]

Front Med (Lausanne)
Wu Y, Jia Y, Jiang M, Zhang H.
europepmc   +1 more source

Community-acquired Acinetobacter pneumonia associated with Evans syndrome: a case report. [PDF]

Ann Med Surg (Lond)
Rasheed S, Adnan H, Arif R, Bai S, Alhassan A, Haseeb A.   +5 more
europepmc   +1 more source

A practical approach to immune thrombocytopenia in pregnancy. [PDF]

Hematology Am Soc Hematol Educ Program
Matusiak K, Malinowski AK, Arnold DM.
europepmc   +1 more source

The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis. [PDF]

PLoS One
Li Y, Kong D, Ding Y, Wang J.
europepmc   +1 more source

IgA Vasculitis (Henoch-Schönlein Purpura) in a Seven-Year-Old Female Child With Recurrent Respiratory Infections. [PDF]

Cureus
Sleem M, Padgett S, Rezk A.
europepmc   +1 more source

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 11/03/2010, Revision: 23, Status: Authorised

Case Medical Research, 2019
null null
semanticscholar   +4 more sources

Human medicines European public assessment report (EPAR): Nplate, romiplostim, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 04/02/2009, Revision: 20, Status: Authorised

Case Medical Research, 2018
null null
semanticscholar   +3 more sources